Comparison of life participation activities among adults treated by hemodialysis, peritoneal dialysis, and kidney transplantation: a systematic review TS Purnell, P Auguste, DC Crews, J Lamprea-Montealegre, T Olufade, ... American Journal of Kidney Diseases 62 (5), 953-973, 2013 | 311 | 2013 |
Validez en la evaluación de escalas JA Lamprea, C Gómez-Restrepo Revista Colombiana de psiquiatría 36 (2), 340-348, 2007 | 174 | 2007 |
Prevalence of hypertension and cardiovascular risk according to blood pressure thresholds used for diagnosis JA Lamprea-Montealegre, LR Zelnick, YN Hall, N Bansal, IH de Boer Hypertension 72 (3), 602-609, 2018 | 57 | 2018 |
Apolipoprotein B, triglyceride-rich lipoproteins, and risk of cardiovascular events in persons with CKD JA Lamprea-Montealegre, N Staplin, WG Herrington, R Haynes, ... Clinical Journal of the American Society of Nephrology 15 (1), 47-60, 2020 | 55 | 2020 |
Chronic kidney disease, lipids and apolipoproteins, and coronary heart disease: the ARIC study JA Lamprea-Montealegre, AR Sharrett, K Matsushita, E Selvin, M Szklo, ... Atherosclerosis 234 (1), 42-46, 2014 | 52 | 2014 |
Chronic kidney disease, plasma lipoproteins, and coronary artery calcium incidence: the Multi-Ethnic Study of Atherosclerosis JA Lamprea-Montealegre, RL McClelland, BC Astor, K Matsushita, ... Arteriosclerosis, thrombosis, and vascular biology 33 (3), 652-658, 2013 | 43 | 2013 |
Association of race and ethnicity with prescription of SGLT2 inhibitors and GLP1 receptor agonists among patients with type 2 diabetes in the Veterans Health Administration System JA Lamprea-Montealegre, E Madden, SL Tummalapalli, C Peralta, ... Jama 328 (9), 861-871, 2022 | 39 | 2022 |
Effectiveness of informational decision aids and a live donor financial assistance program on pursuit of live kidney transplants in African American hemodialysis patients LE Boulware, PL Ephraim, J Ameling, LP Lewis-Boyer, H Rabb, RC Greer, ... BMC nephrology 19, 1-14, 2018 | 38 | 2018 |
CKD, plasma lipids, and common carotid intima-media thickness: results from the multi-ethnic study of atherosclerosis JA Lamprea-Montealegre, BC Astor, RL McClelland, IH de Boer, ... Clinical Journal of the American Society of Nephrology 7 (11), 1777-1785, 2012 | 35 | 2012 |
Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study JA Lamprea‐Montealegre, LR Zelnick, MG Shlipak, JS Floyd, ... Journal of the American Heart Association 8 (15), e012200, 2019 | 32 | 2019 |
Coronary heart disease risk associated with the dyslipidaemia of chronic kidney disease JA Lamprea-Montealegre, RL McClelland, M Grams, P Ouyang, M Szklo, ... Heart 104 (17), 1455-1460, 2018 | 31 | 2018 |
Chronic kidney disease detection, staging and treatment in cardiovascular disease prevention JA Lamprea-Montealegre, MG Shlipak, MM Estrella Heart 107 (16), 1282-1288, 2021 | 27 | 2021 |
Psiquiatría clínica CG Restrepo, GH Bayona, AR Urrego, HS Oleas, MU Restrepo Ed. Médica Panamericana, 2008 | 19 | 2008 |
Estimated prevalence and testing for albuminuria in US adults at risk for chronic kidney disease CD Chu, F Xia, Y Du, R Singh, DS Tuot, JA Lamprea-Montealegre, ... JAMA network open 6 (7), e2326230-e2326230, 2023 | 17 | 2023 |
Prescription patterns of cardiovascular-and kidney-protective therapies among patients with type 2 diabetes and chronic kidney disease JA Lamprea-Montealegre, E Madden, SL Tummalapalli, CD Chu, ... Diabetes Care 45 (12), 2900-2906, 2022 | 16 | 2022 |
Reevaluating the evidence for blood pressure targets in type 2 diabetes JA Lamprea-Montealegre, IH de Boer Diabetes Care 41 (6), 1132, 2018 | 16 | 2018 |
Coverage, formulary restrictions, and affordability of sodium-glucose cotransporter 2 inhibitors by US insurance plan types SL Tummalapalli, JL Montealegre, N Warnock, M Green, SA Ibrahim, ... JAMA Health Forum 2 (12), e214205-e214205, 2021 | 15 | 2021 |
Valvular Heart Disease in Relation to Race and Ethnicity: JACC Focus Seminar 4/9 JA Lamprea-Montealegre, S Oyetunji, R Bagur, CM Otto Journal of the American College of Cardiology 78 (24), 2493-2504, 2021 | 14 | 2021 |
Association of High‐Density Lipoprotein Particles and High‐Density Lipoprotein Apolipoprotein C‐III Content With Cardiovascular Disease Risk According to Kidney Function: The … JA Lamprea‐Montealegre, RL McClelland, JD Otvos, S Mora, M Koch, ... Journal of the American Heart Association 8 (24), e013713, 2019 | 10 | 2019 |
Validity in Scale-testing JA Lamprea, C Gómez-Restrepo Revista Colombiana de Psiquiatría 36 (2), 340-348, 2007 | 10 | 2007 |